Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-06-13

Clinical Trial Update: Urotensin II in Chronic Kidney Diseases and Kidney Transplants

View source ↗

Summary

A clinical trial evaluating Urotensin II in chronic kidney disease and kidney transplant recipients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Vakif Gureba Training and Research Hospital | Conditions: Chronic Renal Disease | Status: COMPLETED